The precision and sensitivity of 18F-fluoride PET for measuring regional bone metabolism: A comparison of quantification methods

Journal of Nuclear Medicine

Volumn 52, Issue 11, 2011, Pages 1748-1755

  Siddique, Musib ^a   Frost, Michelle L ^a   Blake, Glen M ^a   Moore, Amelia E B ^a   Al Beyatti, Yosra ^a   Marsden, Paul K ^a   Schleyer, Paul J ^a   Fogelman, Ignac ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

18F fluoride; Bone metabolism; Positron emission tomography; Precision errors; Sensitivity

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; FLUORINE 18; PARATHYROID HORMONE[1-34];

ACCURACY; AGED; ANALYTICAL ERROR; ARTICLE; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG RESPONSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; LUMBAR SPINE; MATHEMATICAL MODEL; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

AGED; FEMALE; FLUORIDES; FLUORINE RADIOISOTOPES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; LUMBAR VERTEBRAE; POSITRON-EMISSION TOMOGRAPHY; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY;

EID: 80455168431     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.093195     Document Type: Article

References (27)

1. Hawkins RA, Choi Y, Huang S-C, et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med. 1992;33:633-642.
2. Schiepers C, Nuyts J, Bormans G, et al. Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med. 1997;38:1970-1976. (Pubitemid 28030932)
3. 18F-fluoride positron emission tomography. J Bone Miner Res. 2002;17:854-859.
4. Frost ML, Cook GJR, Blake GM, et al. A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography. J Bone Miner Res. 2003;18:2215-2222. (Pubitemid 37463315)
5. 18F-fluoride PET for monitoring therapeutic response in Paget's disease of bone. J Nucl Med. 2005;46:1650-1658.
6. Uchida K, Nakajima H, Miyazaki T, et al. Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study. J Nucl Med. 2009;50:1808-1814.
7. 18F-fluoride positron emission tomography. J Bone Miner Res. 2011;26:1002-1011.
8. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of recombinant human parathyroid hormone (1-34) fragment on spine and non-spine fractures and bone mineral density in postmenopausal osteoporosis. N Engl J Med. 2001;344: 1434-1441. (Pubitemid 32402100)
9. Chesnut CH, Skag A, Christiansen C, et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004;19:1241-1249. (Pubitemid 41094364)
10. Black DM, Delmas PD, Eastell R, et al. Once-yearly zolendronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356:1809-1822. (Pubitemid 46698462)
11. Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361: 756-765.
12. McClung MR, San Martin J, Miller PD, et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med. 2005;165:1762-1768. (Pubitemid 41138965)
13. Arlot M, Meunier PJ, Boivin G, et al. Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters. J Bone Miner Res. 2005;20:1244-1253. (Pubitemid 40863814)
14. Lindsay R, Zhou H, Cosman F, et al. Effects of a one-month treatment with PTH (1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium. J Bone Miner Res. 2007;22:495-502. (Pubitemid 47457425)
15. Garnero P, Weichung JS, Gineyts E, et al. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab. 1994;79:1693-1700.
16. Glover SJ, Eastell R, McCloskey EV, et al. Rapid and robust response of biochemical markers of bone formation to teriparatide therapy. Bone. 2009; 45:1053-1058.
17. 99mTc-methylene diphosphonate. Semin Nucl Med. 2001;31:28-49.
18. Sowers MF, Karvonen-Gutierrez CA. Epidemiological methods in studies of osteoporosis. In: Marcus R, Feldman D, Nelson DA, Rosen CJ, eds. Osteoporosis. 3rd ed. Burlington, MA: Elsevier Academic Press; 2007:645-665.
19. 18F-fluoride PET scans. J Nucl Med. 2004;45:1493-1500.
20. Cunningham VJ, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab. 1993;13:15-23. (Pubitemid 23016599)
21. Lau CY, Lun DP-K, Feng D. Non-invasive quantification of physiological processes with dynamic PET using blind deconvolution. Proceedings of the 1998 IEEE International Conference on Acoustics, Speech and Signal Processing, May 12-15, 1998, Seattle, Washington. Vol 3. Piscataway, NJ: IEEE;1998: 1805-1808.
22. Cook GJ, Lodge MA, Marsden PK, et al. Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions. Eur J Nucl Med. 1999;26:1424-1429. (Pubitemid 29515603)
23. 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism. J Nucl Med. 2008;49:700-707.
24. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716-723.
25. Glüer C-C, Blake G, Lu Y, Blunt BA, Jergas M, Genant HK. Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int. 1995;5:262-270.
26. Lockhart CM, MacDonald LR, Alessio AM, McDougald WA, Doot RK, Kinahan PE. Quantifying and reducing the effect of calibration error on variability of PET/CT standardized uptake value measurements. J Nucl Med. 2011;52:218-224.
27. Blake GM, Siddique M, Frost ML, Moore AE, Fogelman I. Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover? Bone. 2011;49:537-542.